$465.88
5.931.29%
Last update: Nov 11, 12:21 PM
Synopsys Inc
SNPSNASDAQ
Synopsys rose 16.3% from $395.60 to $459.95, ahead of the S&P 500's +9.8%. Its worst day was May 28 (−8.6%), and its low came Sep 15 at $367.70.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Synopsys shares rose 11.6%, while the S&P 500 rose 0.1%.
+11.6% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
EPS of $2.90 beat the $2.30 estimate on $2.3B revenue (est. $2.2B); Q1 revenue guidance of $2.4B–$2.4B against the $2.4B consensus.
+0.3% · S&P 500 +0.2%
Synopsys shares fell 8.5%, while the S&P 500 fell 0.8%.
−8.5% · S&P 500 −0.8%
EPS of $3.77 beat the $3.11 estimate on $2.4B revenue (est. $2.4B); FY revenue guidance of $9.6B–$9.7B against the $9.6B consensus.
−5.2% · S&P 500 −0.6%
Synopsys shares rose 9.6%, while the S&P 500 rose 0.8%.
+9.6% · S&P 500 +0.8%
EPS of $3.35 beat the $2.98 estimate on $2.3B revenue (est. $2.3B); FY revenue guidance of $9.6B–$9.7B against the $9.6B consensus.
−8.6%, the year's worst day · S&P 500 +0.6%
Synopsys shares fell 7.9%, while the S&P 500 fell 1.0%.
−7.9% · S&P 500 −1.0%
EPS of $3.91 beat the $3.47 estimate on $2.5B revenue (est. $2.4B); FY revenue guidance of $9.7B–$9.7B against the $9.7B consensus.
+13.4%, the year's best day · S&P 500 +0.7%
Synopsys closed at its lowest level of the year, 7.1% below where the year started.
−3.6% · S&P 500 −0.5%
Synopsys (NASDAQ:SNPS) is looking for FY2027 Adj EPS of $19.04-$19.12 vs $17.32 analyst estimate.
+12.8%, on 7M shares, the year's heaviest volume · S&P 500 +0.2%
Where it ended: a close of $459.95 on Nov 10, 2026. Up next: Q4 2026 earnings on Dec 8, 2026 (EPS est. $3.92, revenue est. $2.6B).
Nothing in the past 12 months.
All SNPS dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SNPS and SPY from Benzinga historical bars. Not investment advice.
